Designation
Head of Department - Department of Cardiothoracic and Vascular Surgery
Clinical Director of Heart and Lung Transplantation & Mechanical Heart Programme
Institution
National Heart Institute
Qualification
DIMP, MD(UKM), MS (General Surgeon), Fellowship in Transplantation (Cambridge)
2007: Advance Fellowship in Thoracic Transplantation & Mechanical Circulatory Support, Royal Papworth Hospital, Cambridge, United Kingdom
1999 �¢?? 2003: Master of General Surgery Degree, National University if Malaysia Medical Centre (PPUM)
1991 �¢?? 1996: Doctor of Medicine/MD , Medical Faculty, National University of Malaysia (UKM)
Malaysian Medical Council (MMC) 33236
National Specialist Register (NSR) 129840
General Medical Council (UK) 6157151
Special field of interest
Adult Cardiothoracic and vascular surgery
Heart and Lung Transplantation
Mechanical Circulatory Support
Abstract
| Title: |
Reducing Residual risk in LVAD: Lessons from ARIES-HM 3 Trial |
| Body: |
Despite significant advancements in left ventricular assist device (LVAD) technology, residual risks such as thromboembolic events, bleeding, and pump thrombosis continue to pose challenges to long-term outcomes. The ARIES-HM3 trial provides critical insights into optimizing antithrombotic management in patients with the HeartMate 3 LVAD. The key findings from the ARIES-HM3 trial and discusses their implications for clinical practice in reducing residual risk. Integrating lessons from ARIES-HM3 into routine care can potentially enhance the safety and quality of life for LVAD recipients. |
| |
(7.28 KB) |
